Northern Trust
OKUR

Northern Trust’s OnKure Therapeutics OKUR Stock Holding History

Northern Trust’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$899K Buy
197,177
+177,274
+891% +$761K ﹤0.01% 3501
2026
Q1 		$82.4K Hold
19,903
– – ﹤0.01% 4148
2025
Q4 		$57.7K Sell
19,903
-2,607
-12% -$7.8K ﹤0.01% 4257
2025
Q3 		$61.9K Hold
22,510
– – ﹤0.01% 4240
2025
Q2 		$53.8K Buy
22,510
+3,333
+17% +$8.74K ﹤0.01% 4218
2025
Q1 		$82.5K Hold
19,177
– – ﹤0.01% 4152
2024
Q4 		$165K Buy
19,177
+14,776
+336% +$224K ﹤0.01% 4040
2024
Q3 		$74.8K Sell
4,401
-7,385
-63% -$109K ﹤0.01% 4125
2024
Q2 		$178K Buy
11,786
+572
+5% +$9.7K ﹤0.01% 3898
2024
Q1 		$186K Sell
11,214
-450
-4% -$7.42K ﹤0.01% 3920
2023
Q4 		$187K Sell
11,664
-362
-3% -$22.6K ﹤0.01% 3918
2023
Q3 		$916K Buy
12,026
+2,018
+20% +$137K ﹤0.01% 3330
2023
Q2 		$657K Buy
10,008
+8,505
+566% +$685K ﹤0.01% 3471
2023
Q1 		$89.9K Buy
1,503
+312
+26% +$11.3K ﹤0.01% 4108
2022
Q4 		$27.7K Hold
1,191
– – ﹤0.01% 4415
2022
Q3 		$40K Hold
1,191
– – ﹤0.01% 4386
2022
Q2 		$31K Sell
1,191
-5,651
-83% -$132K ﹤0.01% 4548
2022
Q1 		$201K Buy
6,842
+487
+8% +$27.3K ﹤0.01% 4128
2021
Q4 		$544K Buy
6,355
+452
+8% +$33.2K ﹤0.01% 3776
2021
Q3 		$439K Sell
5,903
-942
-14% -$79.9K ﹤0.01% 3813
2021
Q2 		$639K Buy
+6,845
New +$763K ﹤0.01% 3636

Other funds holding OKUR

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
SG
StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Northern Trust's OKUR Position: Q2 2026 in Review

Northern Trust increased its OnKure Therapeutics (OKUR) stake by 891% in Q2 2026, buying an estimated $761K and bringing the position to 197,177 shares worth $899K. The position accounts for ﹤0.01% of the portfolio, ranked #3501.

Northern Trust first reported a position in OKUR in Q2 2021 and has held it in 21 quarters since. The position peaked at $916K in Q3 2023. 75 funds tracked by Wall St. Rank hold OKUR as of Q2 2026.

  • Northern Trust held 197,177 shares of OnKure Therapeutics worth $899K as of Q2 2026.
  • Northern Trust bought 177,274 OnKure Therapeutics shares in Q2 2026, an estimated $761K.
  • OnKure Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #3501 holding.
  • Northern Trust first reported a position in OnKure Therapeutics in Q2 2021 and has held it in 21 quarters since.
  • Northern Trust's OnKure Therapeutics position peaked at $916K in Q3 2023.
  • 75 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.